These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 26158891)
1. Narcolepsy in African Americans. Kawai M; O'Hara R; Einen M; Lin L; Mignot E Sleep; 2015 Nov; 38(11):1673-81. PubMed ID: 26158891 [TBL] [Abstract][Full Text] [Related]
2. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Okun ML; Lin L; Pelin Z; Hong S; Mignot E Sleep; 2002 Feb; 25(1):27-35. PubMed ID: 11833858 [TBL] [Abstract][Full Text] [Related]
3. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503 [TBL] [Abstract][Full Text] [Related]
4. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492 [TBL] [Abstract][Full Text] [Related]
5. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989 [TBL] [Abstract][Full Text] [Related]
6. Correlation between HLA-DQB1*06:02 and narcolepsy with and without cataplexy: approving a safe and sensitive genetic test in four major ethnic groups. A systematic meta-analysis. Capittini C; De Silvestri A; Terzaghi M; Scotti V; Rebuffi C; Pasi A; Manni R; Martinetti M; Tinelli C Sleep Med; 2018 Dec; 52():150-157. PubMed ID: 30321823 [TBL] [Abstract][Full Text] [Related]
7. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354 [TBL] [Abstract][Full Text] [Related]
8. Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency. Andlauer O; Moore H; Jouhier L; Drake C; Peppard PE; Han F; Hong SC; Poli F; Plazzi G; O'Hara R; Haffen E; Roth T; Young T; Mignot E JAMA Neurol; 2013 Jul; 70(7):891-902. PubMed ID: 23649748 [TBL] [Abstract][Full Text] [Related]
9. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400 [TBL] [Abstract][Full Text] [Related]
10. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Han F; Lin L; Schormair B; Pizza F; Plazzi G; Ollila HM; Nevsimalova S; Jennum P; Knudsen S; Winkelmann J; Coquillard C; Babrzadeh F; Strom TM; Wang C; Mindrinos M; Fernandez Vina M; Mignot E Sleep; 2014 Oct; 37(10):1601-8. PubMed ID: 25197808 [TBL] [Abstract][Full Text] [Related]
11. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608 [TBL] [Abstract][Full Text] [Related]
12. A series of 7 cases of patients with narcolepsy with hypocretin deficiency without the HLA DQB1*06:02 allele. Miano S; Barateau L; De Pieri M; Riccardi S; Thevenin C; Manconi M; Dauvilliers Y J Clin Sleep Med; 2023 Dec; 19(12):2053-2057. PubMed ID: 37539640 [TBL] [Abstract][Full Text] [Related]
13. HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy. Jeong JH; Hong SC; Shin YK; Han JH; Lee SP J Korean Med Sci; 2007 Feb; 22(1):127-31. PubMed ID: 17297265 [TBL] [Abstract][Full Text] [Related]
14. Daytime sleepiness with and without cataplexy in Chinese-Taiwanese patients. Huang YS; Tafti M; Guilleminault C Sleep Med; 2006 Aug; 7(5):454-7. PubMed ID: 16815745 [TBL] [Abstract][Full Text] [Related]
15. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Ruoff C; Rye D Curr Med Res Opin; 2016 Oct; 32(10):1611-1622. PubMed ID: 27359185 [TBL] [Abstract][Full Text] [Related]
16. [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia]. MartÃnez-RodrÃguez JE; Iranzo A; Casamitjana R; Graus F; Santamaria J Med Clin (Barc); 2007 Mar; 128(10):361-4. PubMed ID: 17386240 [TBL] [Abstract][Full Text] [Related]
17. Whole-genome analysis of monozygotic Brazilian twins discordant for type 1 narcolepsy: a case report. Campos JHC; Aguilar ACR; Antoneli F; Truzzi G; Briones MRS; Ferreira RC; Coelho FMS BMC Neurol; 2022 Nov; 22(1):439. PubMed ID: 36401198 [TBL] [Abstract][Full Text] [Related]
18. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings. Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990 [TBL] [Abstract][Full Text] [Related]
19. Association Study of HLA-DQB1*0602 Allele in Iranian Patients with Narcolepsy. Geremew D; Rahimi-Golkhandan A; Sadeghniiat-Haghighi K; Shakiba Y; Khajeh-Mehrizi A; Ansaripour B; Izad M Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):452-456. PubMed ID: 29149785 [TBL] [Abstract][Full Text] [Related]
20. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy. Lopez R; Barateau L; Evangelista E; Chenini S; Robert P; Jaussent I; Dauvilliers Y Sleep; 2017 Jan; 40(1):. PubMed ID: 28364477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]